Key points are not available for this paper at this time.
Patients had either a prostate-specific antigen (PSA) elevation (PSA >4.0 ng/mL) or abnormal findings on a digital rectal examination. They were randomly allocated to the control (group 1, n=51) and experimental groups (group 2, n=51). Exclusion criteria were any anorectal pathology, hearing loss, any psychiatric disease, current analgesic medication, allergy to
Turğut et al. (2021) studied this question.